Our results showed that shRNA-mediated SALL4 inhibition induced the loss of stemness in ESCC cells through decreasing the expression levels of Sox2, Oct4 and Nanog, which was in agreement with previous studies. The gene discussed is NANOG; the disease is esophageal squamous cell carcinoma.